Vis, Inc

Founded in 2021 through the strategic merger of VIS LLC and NTK Enterprises, Inc, VIS, Inc. combines innovation and expertise to redefine optical healthcare. This merger provided VIS with full ownership of the intellectual property (IP) behind Opti-K™, a patented laser-based optical procedure and proprietary system for the treatment of presbyopia. Opti-K™ is just the beginning of VIS’s ambitious acquisition strategy. At VIS, our mission is to revolutionize vision care by acquiring, developing, and commercializing proven medical laser-based optical devices and procedures. Our goal is to build a diverse portfolio of innovative solutions that deliver safe, fast, and affordable treatments with outstanding results. Future Focus With a team of seasoned professionals and a proven track record in product acquisition, development, market entry, and commercialization, VIS is committed to expanding its portfolio of laser-based optical solutions. Our vision is to empower ophthalmologists with state-of-the-art tools to enhance patient outcomes and transform lives. Opti-K™ is a groundbreaking, noninvasive laser-based procedure designed to address near vision issues caused by presbyopia, hyperopia, myopia, and age-related macular degeneration (AMD). In just three painless seconds, Opti-K™ offers a repeatable, cost-effective alternative to traditional eyeglasses, contact lenses, and invasive procedures like LTK, CK, and LASIK, which carry known risks. Key benefits of Opti-K™ include: Safety and Simplicity: A noninvasive procedure with a rapid recovery time. Affordability and Accessibility: Designed to make cutting-edge vision care widely available. Exceptional Results: Immediate improvements with a one-year satisfaction guarantee. The unparalleled ease of use, patient satisfaction, and affordability of Opti-K™ are expected to drive its widespread adoption, setting a new standard in vision care.